Launch week offerEnds in00h00m00s

annual Promonthly Pro

Nelson Dusetti

Cancer Research Center of Marseille

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Cell Biology Cell Biology professors in France

Articles (16)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Marisa Nishio

Assistant Professor

Kyoto University

JAPAN

View details

Juan Iovanna

DRCE

INSERM

FRANCE

View details

Ling Peng

Research Director

CNRS

FRANCE

View details

Christof Lenz

Director Core Facility Proteomics

University Medical Center Göttingen

GERMANY

View details

Teodora‐Adriana Perles‐Barbacaru

Associate Professor

Aix-Marseille University

FRANCE

View details

Jean-François Emile

Université de Versailles Saint-Quentin-en-Yvelines

FRANCE

View details

Laetitia Karine Linares

senior scientist / Team Leader

INSERM Délégation Régionale Occitanie Méditerranée

FRANCE

View details

Ilse Rooman

Head/Professor

Vrije Universiteit Brussel

BELGIUM

View details

Michael Zimmermann

Associate Professor

Medical College of Wisconsin

UNITED STATES

View details

Philippe Giron

Vrije Universiteit Brussel

BELGIUM

View details

Karol Nowicki-Osuch

Junior Group Leader

Deutsches Krebsforschungszentrum

GERMANY

View details

Philippe Soubeyran

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nelson Dusetti

Research Interests

Make your next move.

Explore related searches

Articles (16)

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries

Self-assembling dendrimer nanodrug formulations for decreased hERG- related toxicity and enhanced therapeutic efficacy

Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures

Understanding the heterogeneity of pancreatic ductal adenocarcinoma

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer

Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type

High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.

Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo

SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer

A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma

Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking

Collaborators (12)

Marisa Nishio

Juan Iovanna

Ling Peng

Christof Lenz

Teodora‐Adriana Perles‐Barbacaru

Jean-François Emile

Laetitia Karine Linares

Ilse Rooman

Michael Zimmermann

Philippe Giron

Karol Nowicki-Osuch

Philippe Soubeyran

Make your next move.